ENDRA Life Sciences Inc.
+13.4% · 90d
$4.82
-0.15 (-3.02%)
After-Hours $4.75(+0.11)
News
(1)March 2026
ENDRA Life Sciences Inc. — 8-K Filing
NDRAENDRA Life Sciences Inc.
# 🧾 What This Document Is This is an 8-K filing, which is a report of unscheduled, material events that a public company must file with the SEC. It includes a press release with two main things: their financial results for the last quarter and year (Q4 and full-year 2025), and a major business upd
Read summaryView on SEC EDGAR
Peers in Diagnostics & Research
TMO#1
Thermo Fisher Scientific Inc.
$185.98B-0.60%
DHR#2
Danaher Corporation
$136.58B-1.63%
IDXX#3
IDEXX Laboratories, Inc.
$46.56B-1.20%
A#4
Agilent Technologies, Inc.
$32.61B-1.31%
WAT#5
Waters Corporation
$31.16B-0.28%
NTRA#6
Natera, Inc.
$28.77B-3.71%
IQV#7
IQVIA Holdings Inc.
$28.37B-2.06%
MTD#8
Mettler-Toledo International Inc.
$27.03B+0.93%
LH#9
Labcorp Holdings Inc.
$22.52B-0.53%
DGX#10
Quest Diagnostics Incorporated
$21.90B-0.50%